Oncogenic signalling crosstalk between MYD88 and CD79B mutations
Researchers
- Dr Keisuke Horikawa (Primary Investigator)
Grant status
CompletedGrant start date
01/01/2019Grant funding
- 2019: $269,462 from National Health and Medical Research Council (NHMRC)
- 2020: $284,462 from National Health and Medical Research Council (NHMRC)
- 2021: $294,462 from National Health and Medical Research Council (NHMRC)